|
|
|
Insider
Information: |
Aselage Steve |
Relationship: |
Director |
City: |
Fremont |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
293,421 |
|
Indirect Shares
|
19,500 |
|
|
Direct
Value |
$6,622,171 |
|
|
Indirect Value
|
$117,000 |
|
|
Total
Shares |
312,921 |
|
|
Total
Value |
$6,739,171 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
4
|
5
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
4
|
2
|
|
|
|
Gain/Loss Ratio : |
-4.0
|
1.5
|
Percentage
Gain/Loss : |
-31.1%
|
62.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cti Biopharma Corporation |
CTIC |
EVP, Global Commercial... |
2005-06-30 |
24,133 |
2004-08-03 |
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Business Of... |
2012-07-02 |
59,030 |
2006-04-28 |
0 |
Premium* |
|
Travere Therapeutics, Inc |
TVTX |
Director |
2022-05-11 |
146,919 |
2021-11-05 |
19,500 |
Premium* |
|
Acer Therapeutics Inc |
ACER |
Director |
2023-11-17 |
0 |
2017-09-19 |
0 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2023-06-13 |
63,339 |
2019-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
169 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CTIC |
Cti Biopharma Corporation |
EVP, Global Commercial Ops |
|
2004-02-18 |
4 |
B |
$8.90 |
$54,000 |
D/D |
6,000 |
6,000 |
2.74 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Global Commercial Ops |
|
2004-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
16,000 |
|
- |
|
CTIC |
Cti Biopharma Corporation |
EVP Global Commercial Ops |
|
2004-08-03 |
4 |
B |
$5.25 |
$21,000 |
D/D |
4,000 |
20,000 |
2.74 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP Global Comm Operations |
|
2004-12-20 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
30,000 |
|
- |
|
CTIC |
Cti Biopharma Corporation |
EVP Global Comm Operations |
|
2005-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
130,800 |
|
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Global Commercial Ops |
|
2005-06-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(106,667) |
24,133 |
|
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Ops |
|
2006-04-28 |
4 |
A |
$6.92 |
$6,635 |
D/D |
959 |
959 |
|
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Ops |
|
2006-10-31 |
4 |
B |
$6.92 |
$12,939 |
D/D |
1,870 |
2,829 |
2.74 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Ops |
|
2006-11-29 |
4 |
S |
$17.23 |
$86,150 |
D/D |
(5,000) |
2,829 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Ops |
|
2006-11-29 |
4 |
OE |
$7.16 |
$35,800 |
D/D |
5,000 |
7,829 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Ops |
|
2007-02-14 |
4 |
OE |
$7.16 |
$107,400 |
D/D |
15,000 |
17,829 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Ops |
|
2007-02-14 |
4 |
AS |
$20.00 |
$300,000 |
D/D |
(15,000) |
2,829 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2007-04-30 |
4 |
B |
$6.92 |
$14,295 |
D/D |
2,066 |
4,895 |
2.74 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2007-08-10 |
4 |
OE |
$7.16 |
$143,200 |
D/D |
20,000 |
24,895 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2007-08-10 |
4 |
S |
$20.21 |
$405,389 |
D/D |
(20,000) |
4,895 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev. |
|
2007-09-14 |
4 |
S |
$22.40 |
$224,000 |
D/D |
(10,000) |
4,895 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev. |
|
2007-09-14 |
4 |
OE |
$7.16 |
$71,600 |
D/D |
10,000 |
14,895 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2007-10-01 |
4 |
AS |
$24.90 |
$125,471 |
D/D |
(5,000) |
4,895 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2007-10-01 |
4 |
OE |
$7.16 |
$35,800 |
D/D |
5,000 |
9,895 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2007-10-31 |
4 |
AB |
$6.92 |
$14,800 |
D/D |
2,139 |
7,034 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2008-01-02 |
4 |
OE |
$7.16 |
$35,800 |
D/D |
5,000 |
12,034 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2008-01-02 |
4 |
AS |
$35.28 |
$180,398 |
D/D |
(5,000) |
7,034 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2008-03-03 |
4 |
S |
$38.00 |
$1,520,000 |
D/D |
(40,000) |
32,034 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2008-03-03 |
4 |
OE |
$7.16 |
$593,640 |
D/D |
65,000 |
72,034 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2008-04-01 |
4 |
OE |
$7.16 |
$5,764 |
D/D |
805 |
32,839 |
0 |
- |
|
169 Records found
|
|
Page 1 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|